Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether cyclosporine microemulsion given once a day
instead of twice a day benefits kidney function, blood pressure, lipid profile and glucose
control in stable liver transplant recipients. The study also aims to identify the target
ranges of levels of cyclosporine microemulsion in the blood.